Aclaris Therapeutics, Inc. · NASDAQ:ACRS

Vivo Opportunity Fund Holdings, L.P.'s stake in Aclaris Therapeutics, Inc. fell to 4.30% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 12, 2026

Vivo Opportunity Fund Holdings, L.P.'s stake in Aclaris Therapeutics, Inc. fell to 4.30%, 5,966,370 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).

Stake
4.30%
Shares
5,966,370
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Vivo Opportunity Fund Holdings, L.P.4.30%5,966,370
Vivo Opportunity, LLC4.30%5,966,370
Vivo Opportunity Cayman Fund, L.P.0.50%700,296
Vivo Opportunity Cayman, LLC0.50%700,296

Source

View original at SEC

Related